NDUBUISI ODEGAI: Open Payments
NPI 1508378514 · AUBREY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 33 payments from 5 companies in 2025. Trend: 2023 $586 · 2024 $874 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $254 |
| Otsuka America Pharmaceutical, Inc. | 6 | $133 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $15 |
Products named: VRAYLAR, REXULTI, Qelbree, Auvelity.
Industry payments across TX — which companies pay providers there.
